BOSTON (January 20, 2015) – International law firm McDermott Will & Emery today announced that it has appointed Sarah Hogan as a partner in its Health Industry Advisory Practice Group, resident in the Boston office.
Ms. Hogan, who joins from Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., focuses on advising clients in the health information technology (IT) and life sciences licensing areas. She counsels health care, information technology, and biotechnology companies at all stages of development on commercialization of their technology and intellectual property assets. Sarah’s work includes advising on IT contracts related to mergers and strategic alliances, licensing, outsourcing, technology development, data storage and other corporate partnering transactions.
Most recently, Ms. Hogan was integral to the contract negotiations between the Commonwealth of Massachusetts and its health insurance exchange IT vendor, helping to facilitate web-based purchases of health insurance to Bay State residents.
“Improving care at reduced cost as embraced by the Affordable Care Act has incentivized both health providers and insurers to implement more effective methods of tracking quality outcomes in order to be reimbursed. As a result, the demand for technology that ensures effective and secure sharing of patient information is critical,” explained Stephen W. Bernstein, partner and International Head of McDermott’s Health Industry Advisory Group. “As client demand for counsel who understand the intersections of patient information, technology, business and the complex regulatory environment continues to accelerate, Sarah’s wide-ranging experience will supplement our existing team and further our capabilities to continue to deliver pragmatic solutions to our clients.”
Ms. Hogan has represented both technology services companies as well as major companies in their licensing of associated technologies. She has significant experience assisting clients in managing relationships with technology vendors, including advising on technology acquisition, vendor management, privacy concerns, international matters, intellectual property protection, and related contractual issues.
Ms. Hogan is a former scientist with degrees in biotechnology and genetics and comprehensive life sciences industry knowledge. Ms. Hogan received her J.D. from Northeastern University School of Law in 2005; her M.S. in Genetics from University of New Hampshire in 1999 and her B.S. in Biotechnology from Worchester Polytechnic Institute in 1996.
With an over 30-year history of serving the health care industry, McDermott Will & Emery has one of the most prestigious health law practice groups in the world. The Firm’s international health team, resident in its Boston, Chicago, Los Angeles, Miami, Munich, New York, Rome, Silicon Valley and Washington, D.C. offices, counsels leading organizations in every major sector of the health and life sciences industry on regulatory and business transaction issues. McDermott is the only law firm to receive Tier 1 rankings in health care nationally by all of the industry’s top legal directories: Chambers USA, The Legal 500 USA, U.S. News–Best Lawyers and Law360. For the fifth consecutive year (2010-2014), McDermott’s Health Industry Advisory practice achieved a standalone, Tier 1 national ranking in Chambers USA’s healthcare category.
About McDermott Will & Emery McDermott Will & Emery is a premier international law firm with a diversified business practice. Numbering more than 1,100 lawyers, we have offices in Boston, Brussels, Chicago, Düsseldorf, Frankfurt, Houston, London, Los Angeles, Miami, Milan, Munich, New York, Orange County, Paris, Rome, Seoul, Silicon Valley and Washington, D.C. Further extending our reach into Asia, we have a strategic alliance with MWE China Law Offices in Shanghai.